HomeICCC • NASDAQ
add
ImmuCell Corp
Previous close
$6.37
Day range
$6.32 - $6.49
Year range
$4.52 - $7.60
Market cap
57.76M USD
Avg Volume
13.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 7.63M | -1.61% |
Operating expense | 2.97M | 34.28% |
Net income | -2.85M | -653.68% |
Net profit margin | -37.36 | -662.65% |
Earnings per share | — | — |
EBITDA | 621.09K | -63.51% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.89M | 3.40% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 29.80M | — |
Shares outstanding | 9.05M | — |
Price to book | 1.94 | — |
Return on assets | — | — |
Return on capital | -0.33% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.85M | -653.68% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1982
Headquarters
Website
Employees
81
